Philip S LaRussa

Summary

Affiliation: Columbia University
Country: USA

Publications

  1. ncbi Understanding the role of human variation in vaccine adverse events: the Clinical Immunization Safety Assessment Network
    Philip S LaRussa
    Department of Pediatrics, Division of Pediatric Infectious Diseases, Columbia University, New York, NY, USA
    Pediatrics 127:S65-73. 2011
  2. ncbi Pandemic novel 2009 H1N1 influenza: what have we learned?
    Philip Larussa
    Department of Pediatrics, College of Physicians and Surgeons, Columbia University, New York, New York 10032, USA
    Semin Respir Crit Care Med 32:393-9. 2011
  3. ncbi A phase I-II study of live attenuated varicella-zoster virus vaccine to boost immunity in human immunodeficiency virus-infected children with previous varicella
    Anne A Gershon
    Department of Pediatrics, Columbia University College of Physicians and Surgeons, New York, NY 10032, USA
    Pediatr Infect Dis J 28:653-5. 2009
  4. ncbi Primary vaccine failure after 1 dose of varicella vaccine in healthy children
    David E Michalik
    Division of Pediatric Infectious Diseases, Columbia University Medical Center, New York, New York 10032, USA
    J Infect Dis 197:944-9. 2008
  5. ncbi Effectiveness of 2 doses of varicella vaccine in children
    Eugene D Shapiro
    Department of Pediatrics, Yale University School of Medicine and Graduate School of Arts and Sciences, New Haven, Connecticut 06520 8064, USA
    J Infect Dis 203:312-5. 2011
  6. ncbi Robust take following exposure to vaccinia virus: case definition and guidelines of data collection, analysis, and presentation of immunization safety data
    Philip L Graham
    Department of Pediatrics, College of Physicians and Surgeons, Columbia University, New York, NY, USA; Department of Epidemiology, New York Presbyterian Hospital, New York, NY, USA
    Vaccine 25:5763-70. 2007
  7. ncbi Risk of herpes zoster in adults immunized with varicella vaccine
    Sophie Hambleton
    Department of Pediatrics, Columbia University College of Physicians and Surgeons, New York, New York, USA
    J Infect Dis 197:S196-9. 2008
  8. ncbi Effectiveness over time of varicella vaccine
    Marietta Vazquez
    Department of Pediatrics, Yale University School of Medicine, New Haven, Conn 06520 8064, USA
    JAMA 291:851-5. 2004
  9. ncbi Severe varicella caused by varicella-vaccine strain in a child with significant T-cell dysfunction
    Patrick Jean-Philippe
    Department of Pediatrics, New York University School of Medicine, New York, New York, USA
    Pediatrics 120:e1345-9. 2007

Detail Information

Publications9

  1. ncbi Understanding the role of human variation in vaccine adverse events: the Clinical Immunization Safety Assessment Network
    Philip S LaRussa
    Department of Pediatrics, Division of Pediatric Infectious Diseases, Columbia University, New York, NY, USA
    Pediatrics 127:S65-73. 2011
    ..The CISA Network serves as a unique resource for vaccine-safety monitoring efforts conducted at the CDC...
  2. ncbi Pandemic novel 2009 H1N1 influenza: what have we learned?
    Philip Larussa
    Department of Pediatrics, College of Physicians and Surgeons, Columbia University, New York, New York 10032, USA
    Semin Respir Crit Care Med 32:393-9. 2011
    ..Continued efforts to develop universal vaccines and improve access to effective vaccines are critical...
  3. ncbi A phase I-II study of live attenuated varicella-zoster virus vaccine to boost immunity in human immunodeficiency virus-infected children with previous varicella
    Anne A Gershon
    Department of Pediatrics, Columbia University College of Physicians and Surgeons, New York, NY 10032, USA
    Pediatr Infect Dis J 28:653-5. 2009
    ..There were no serious adverse events. Two years after vaccination 82% of subjects remained VZV-antibody positive and 60% had VZV-specific cell-mediated immunity. No child developed herpes zoster...
  4. ncbi Primary vaccine failure after 1 dose of varicella vaccine in healthy children
    David E Michalik
    Division of Pediatric Infectious Diseases, Columbia University Medical Center, New York, New York 10032, USA
    J Infect Dis 197:944-9. 2008
    ..A second dose of varicella vaccine is expected to increase seroconversion rates and vaccine effectiveness...
  5. ncbi Effectiveness of 2 doses of varicella vaccine in children
    Eugene D Shapiro
    Department of Pediatrics, Yale University School of Medicine and Graduate School of Arts and Sciences, New Haven, Connecticut 06520 8064, USA
    J Infect Dis 203:312-5. 2011
    ..Because of ongoing outbreaks of varicella, a second dose of varicella vaccine was added to the routine immunization schedule for children in June 2006 by the Centers for Disease Control and Prevention...
  6. ncbi Robust take following exposure to vaccinia virus: case definition and guidelines of data collection, analysis, and presentation of immunization safety data
    Philip L Graham
    Department of Pediatrics, College of Physicians and Surgeons, Columbia University, New York, NY, USA; Department of Epidemiology, New York Presbyterian Hospital, New York, NY, USA
    Vaccine 25:5763-70. 2007
  7. ncbi Risk of herpes zoster in adults immunized with varicella vaccine
    Sophie Hambleton
    Department of Pediatrics, Columbia University College of Physicians and Surgeons, New York, New York, USA
    J Infect Dis 197:S196-9. 2008
    ..00 case/1000 person-years. Overall, the incidence of HZ in this cohort, therefore, is similar to published data for the US population in the prevaccine era...
  8. ncbi Effectiveness over time of varicella vaccine
    Marietta Vazquez
    Department of Pediatrics, Yale University School of Medicine, New Haven, Conn 06520 8064, USA
    JAMA 291:851-5. 2004
    ..Reports of outbreaks of varicella in highly immunized groups have increased concern about the effectiveness of varicella vaccine...
  9. ncbi Severe varicella caused by varicella-vaccine strain in a child with significant T-cell dysfunction
    Patrick Jean-Philippe
    Department of Pediatrics, New York University School of Medicine, New York, New York, USA
    Pediatrics 120:e1345-9. 2007
    ..We report here an 18-month-old girl with cell-mediated immunodeficiency who developed a severe vaccine-associated rash and clinical evidence of vaccine-associated pneumonia 1 month after inadvertent receipt of varicella vaccine...